Willow vs BMI MD: Compare GLP-1 Programs & Pricing
Side-by-side Willow and BMI MD: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
Willow and BMI MD are telehealth providers offering GLP‑1–based weight management programs and related clinical oversight. This comparison highlights pricing, enrollment flow, safety considerations, and which service may fit different patient priorities. It does not replace medical advice; consult a licensed clinician for personal recommendations.
Willow vs BMI MD: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| Willow | $299.00 | $399.00 | Best for Oral and Injectable | No |
| BMI MD |
The table shows published starting prices for Willow and the basic program attributes for both providers. Where BMI MD pricing is not published here, prospective patients should review the provider site or speak with intake staff for an exact quote based on medication selection and dosing.
Willow vs BMI MD: Medical Process & Accessibility
Willow is built for rapid telehealth intake with clinician review and same‑or‑next‑day determinations in many cases. BMI MD typically offers structured follow‑ups and dose adjustments as part of ongoing care. Both require a virtual medical evaluation, a documented medical history, and clinician approval before any prescription is issued.
Willow vs BMI MD: Pricing Comparison
Willow lists semaglutide starting at $299.00 and tirzepatide starting at $399.00. BMI MD’s site does not list starting prices in this summary; interested patients should request a detailed quote. Where both prices are available, we bold the lower published amounts for quick comparison.
Willow advertises “Best for Oral and Injectable.” There is no membership fee required for Willow’s basic program. BMI MD may have tiered plans or add‑ons; verify any subscription, telehealth visit fees, or pharmacy shipping costs before enrolling to understand total out‑of‑pocket expense.
Willow vs BMI MD: Clinical Oversight & Follow‑Up
Both providers operate under U.S. telehealth standards and use licensed clinicians to evaluate candidates for GLP‑1 therapy. Clinicians screen for contraindications (for example, personal or family history of certain thyroid tumors, pancreatitis, or other conditions) and will not prescribe if it’s medically inappropriate. Regular follow‑up is recommended to monitor side effects and adjust dosing.
Willow vs BMI MD: Medication Quality & Safety
Telehealth programs commonly dispense prescription GLP‑1 medications through partnered U.S. pharmacies. These compounds may differ from branded, FDA‑approved products. Patients should confirm whether a provider supplies branded or compounded formulations and review pharmacy accreditation. All prescriptions should be issued only after clinical evaluation and in accordance with FDA guidance and state medical practice laws.
Willow vs BMI MD: Customer Experience
User reports often highlight Willow for affordability and easy enrollment, and BMI MD for more hands‑on clinical communication and follow‑up. Shipping times, refill processes, and customer service responsiveness can vary; check recent reviews and ask each provider about expected delivery timelines and return or refill policies.
Willow vs BMI MD: Final Verdict
Choose Willow if fast onboarding and clear published starting prices are your priority. Choose BMI MD if you prefer a program emphasizing ongoing medical follow‑up and individualized dose optimization. Both are legitimate telehealth options; the best choice depends on your budget, need for clinical touchpoints, and preference for branded vs compounded medication options.
Join Willow
Get Started with BMI MD
Disclaimer
This article is informational and not medical advice. Programs, pricing, and availability change; always consult a licensed clinician for a personalized assessment. Some GLP‑1 prescriptions are compounded and are not identical to brand‑name, FDA‑approved formulations. ExploreProviders.com and affiliated pages may receive referral fees at no additional cost to you. Follow clinician guidance and FDA recommendations when considering prescription therapy.